ロード中...
RANKL Inhibition Through Osteoprotegerin Blocks Bone Loss in Experimental Periodontitis
BACKGROUND: Prevention of alveolar bone destruction is a clinical challenge in periodontal disease treatment. The receptor activator of nuclear factor-kappa B ligand (RANKL) inhibitor osteoprotegerin (OPG) inhibits osteoclastogenesis and suppresses bone resorption. METHODS: To study the effects of R...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2583091/ https://ncbi.nlm.nih.gov/pubmed/17608585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1902/jop.2007.070073 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|